Atlas Trials

TAS-102 and Irinotecan in 2L+ Gastric and Gastroesophageal Adenocarcinoma

Clinical trial NCT04074343 · COMPLETED

Trial details

NCT number
NCT04074343
Sponsor
University of California, Irvine
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Gastric AdenocarcinomaGastroEsophageal Cancer
Start date
2019-08-26
Primary completion
2021-07-14
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.